Class actions have been filed in the United States District Court Southern District of California against ACADIA Pharmaceuticals, Inc. (“ACADIA” or the “Company”) (Nasdaq: ACAD) on behalf of purchasers of securities between April 29, 2016 and July 9, 2018 (“Class...
The post ACADIA Pharmaceuticals, Inc. (ACAD) appeared first on Safirstein Metcalf LLP 1-800-221-0015.
source https://www.safirsteinmetcalf.com/acadia-pharmaceuticals-inc-acad/
No comments:
Post a Comment